Low UGP2 Expression Is Associated with Tumour Progression and Predicts Poor Prognosis in Hepatocellular Carcinoma

Table 1

Correlation of clinicopathological characteristics with UGP2 expression in the ZZU HCC cohort.

Variable	All patients (%)	Low UGP2	High UGP2	value
Total	335	192	143
Sex				0.276
Female	73 (21.8)	46	27
Male	262 (78.2)	146	116
Age (years)				0.317
<50	125 (37.3)	74	51
≥50	210 (62.7)	118	102
Liver cirrhosis				0.386
Yes	309 (92.2)	175	134
No	26 (7.8)	17	9
AFP (ng/ml)				0.529
<20	162 (48.4)	90	72
≥20	173 (51.6)	102	71
Tumour multiplicity				0.969
Single	255 (76.1)	146	109
Multiple	80 (23.9)	46	34
Tumour size (cm)				0.563
≤5	186 (55.5)	104	82
>5	149 (44.5)	88	61
Portal vein thrombosis				0.195
Absence	296 (88.4)	165	131
Gross	39 (11.6)	26	13
TNM stage				0.014
Early stage (I-II)	262 (78.2)	141	121
Late stage (III-IV)	73 (21.8)	51	22

Notes: , . Abbreviations: AFP: alpha-fetoprotein; TNM: tumour-node-metastasis.